Volume 10, Issue 1 (3-2022)                   JoMMID 2022, 10(1): 19-23 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbari M H, Ahani Azari A, Fozouni L. Broad-Spectrum Beta-Lactamases and Drug-Resistance Phenotypes of Enterobacteriaceae Isolated from Clinical Specimens in Gonbad-e Kavus, Golestan Province, Iran. JoMMID 2022; 10 (1) :19-23
URL: http://jommid.pasteur.ac.ir/article-1-442-en.html
Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran.
Abstract:   (1531 Views)
Introduction: This study aimed to determine the frequency of extended-spectrum beta-lactamases (ESBL) and different drug resistance phenotypes in Enterobacteriaceae isolated from clinical specimens in Gonbad-e Kavus, Golestan Province. Methods: 220 clinical samples of urine, blood, pus, sputum, CSF, body fluids, and ear and eye discharge were collected during six months from April to September 2021 at a referral hospital. The samples were cultured on blood and MacConkey agar and incubated overnight at 37 °C. Standard biochemical tests and the API20E enteric identification system were used to identify bacteria. The Kirby-Bauer disk diffusion method determined the antibiotic resistance pattern, and the phenotypic confirmatory test was used for detecting ESBL producers. Results: 108 Enterobacteriaceae isolates were identified from different clinical specimens out of the samples. The isolates were Escherichia coli (36.1%), Klebsiella pneumonia (25%), Enterobacter cloacae (18.5%), Citrobacter freundii (11.1%) and Proteus mirabilis (9.2%). The highest resistance and susceptibility among the isolates belonged to sulfamethoxazole-trimethoprim (68.5%) and meropenem (11.1%), respectively. The highest prevalence of multidrug-resistant (MDR) and ESBL were observed in E. coli and Proteus mirabilis isolates. Conclusions: In this study, the high frequency of MDR phenotypes in the isolates may suggest an increasing trend of antibiotic resistance in Enterobacteriaceae. This could greatly impact the management and treatment of infections caused by these drug-resistant bacteria. Therefore, infection-control measures and continuous monitoring is recommended for controlling the spread of ESBL-producing strains in different geographical areas.
Full-Text [PDF 3508 kb]   (780 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2022/01/11 | Accepted: 2022/03/11 | Published: 2022/04/4

References
1. Murray PR, Rosenthal KS MpM. Medical Microbiology 8th ed. Philadelphia, Pennsylvania USA; 2016.
2. Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019; 8 (1): 1-12. [DOI:10.1186/s13756-019-0488-4]
3. Carona Y, Chheanga R, Putheaa N, Sodaa M, Boyerb S, Tarantolac A, Kerléguer A. Beta-lactam resistance among Enterobacteriaceae in Cambodia: The four-year itch. Int J Infect Dis. 2018; 66: 74-79. [DOI:10.1016/j.ijid.2017.10.025]
4. Paterson DL, Bonomo RA. Extended-Spectrum Beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18 (4): 657-86. [DOI:10.1128/CMR.18.4.657-686.2005]
5. Pitout JDLK. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3):159-66. [DOI:10.1016/S1473-3099(08)70041-0]
6. Ghotasloua R, Sadeghia MR, Akhib MT, Hasanib A, Asgharzadeh M. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran. Iran. J Pharm Sci. 2018; 17 (Special Issue): 79-88.
7. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. The Italian ESBL Study Group. Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs. Antimicrob Agents Chemother. 2002; 46 (1): 196-202. [DOI:10.1128/AAC.46.1.196-202.2002]
8. Nwafia IN, Ohanu ME, Ebede SO, Ozumba UC. Molecular detection and antibiotic resistance pattern of extended‑spectrum beta‑lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria. Ann Clin Microbiol Antimicrob. 2019; 18 (1): 41. [DOI:10.1186/s12941-019-0342-9]
9. Clinical and Laboratory Standards Institute. M02: Performance standards for antimicrobial disk susceptibility tests (ISBN: 1-56238-835-5). Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18 (3): 268-81. [DOI:10.1111/j.1469-0691.2011.03570.x]
11. Yousefi Mashouf P, Alijani P, Saidijam M, Alikhani MY, Rashidi H. Study of antibiotic resistance pattern and phenotypic detection of ESBLs in Klebsiella pneumoniae strains isolated from clinical samples and determination of minimum inhibitory concentrations of imipenem and ceftazidim antibiotics. J Hamadan Univ Med Sci. 2014; 20 (4): 295- 302.
12. Adler A, Katz DE, Marchaim D. The continuing plague of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. Infect Dis Clin N Am. 2016; 30 (2): 347-75. [DOI:10.1016/j.idc.2016.02.003]
13. Khanbeyki S, Ahani Azari A, Danesh A. Prevalence and antibiotic resistance pattern of extended spectrum β-Lactamase- (ESBL-) producing gram negative bacilli isolated from clinical samples of hospitalized patients in a hospital in Gorgan. J Torbat Heydariyeh Univ Med Sci. 2020; 8 (2): 47-56.
14. Didgar F, Sarmadian H, Ghasemikhah R. Antimicrobial resistance pattern of Gram -negative bacilli isolated of Vali-Asr Hospital wards in Arak. Iran South Med J. 2014; 17 (5): 938-47.
15. Bayat Maku ZH, Hassani A, Naqili B, Alipour L. Prevalence of gram-negative bacilli producing broad-spectrum beta-lactamases in clinical samples of hospitalized patients. J Tabriz Univ Med Sci. 2010; 32 (4): 11-5.
16. Mansouri SH, Abbasi S. Prevalence of Multiple Drug Resistant Clinical Isolates of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Southeast Iran. Iran J Med Sci. 2010; 35 (2): 101-8.
17. Fendereski A, Ahani Azari A, Dadgar, T. Phenotypic detection of Beta-lactamases among Proteus mirabilis, Enterobacter cloacae, and Citrobacter freundii isolates from urinary samples in Gorgan, Northeast Iran. J Med Microbiol Infect Dis. 2020; 8 (4): 161-5. [DOI:10.29252/JoMMID.8.4.161]
18. Habibi H., Ahani Azari A., Danesh A. Incidence of beta-Lactamase enzymes among Klebsiella pneumonia isolates causing urinary tract infections in Aliabad, North-East Iran. Infect Epidemiol Microbiol. 2020; 6 (3): 193-200. [DOI:10.29252/iem.6.3.193]
19. Hosseini SA, Ahani Azari A, Danesh A. Frequency of various types of beta-Lactamase enzymes in Escherichia coli strains isolated from urine samples in Aliabad, North-east of Iran. Avicenna J Clin Microbiol Infect. 2019; 6 (4): 106-10. [DOI:10.34172/ajcmi.2019.19]
20. Ahani Azari A, Khajeh A, Danesh A. Assessment of antibiotic resistance pattern and frequency of extended spectrum β-lactamases (ESBLs) in gram negative bacteria isolated from urine samples in Bandar-e Torkaman. J Neyshabur Univ Med Sci. 2019; 7 (1): 134-43.
21. Ibrahim M, Abbas M, Al-Shahrai A, Elamin B. Phenotypic Characterization and antibiotic resistance patterns of extended-spectrum β-lactamase- and AmpC β-lactamase-producing gram-negative bacteria in a referral Hospital, Saudi Arabia. Can J Infect Dis Med Microbiol. 2019; 1-9. [DOI:10.1155/2019/6054694]
22. Mousavian SM, Ahmad Khosravi N, Shoja S. Survey of frequency in extended-spectrum beta-Lactamase producing Enterobacteriaceae and determination of the antibiotic resistant pattern in clinical specimens in teaching hospitals of Ahvaz Jundishapur university of medical sciences. Jundishapur Sci Med J. 2013; 13 (2): 191-9.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.